Main menu


Novavax begins early-stage trial in Australia for combined influenza/COVID-19 vaccine

Primary tabs

Novavax begins early-stage trial in Australia for combined influenza/COVID-19 vaccine

Sept 8 (Reuters) - Vaccine developer Novavax Inc (NVAX.O) said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.

The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been previously infected with the coronavirus or given an authorized COVID-19 vaccine at least eight weeks prior to the study....

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.391 seconds.